Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus).

PubWeight™: 0.88‹?›

🔗 View Article (PMID 8615455)

Published in Am J Trop Med Hyg on April 01, 1996

Authors

J N Mills1, J G Barrera Oro, D S Bressler, J E Childs, R B Tesh, J F Smith, D A Enria, T W Geisbert, K T McKee, M D Bowen, C J Peters, P B Jahrling

Author Affiliations

1: National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles by these authors

All ras proteins are polyisoprenylated but only some are palmitoylated. Cell (1989) 9.68

Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39

Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11

Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96

Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02

Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science (1999) 6.94

Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72

Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59

Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol (2000) 6.46

Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol (2000) 6.43

Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96

Chlamydia trachomatis infections in female military recruits. N Engl J Med (1998) 4.68

Clinical recognition and management of patients exposed to biological warfare agents. JAMA (1997) 4.67

Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28

Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03

ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology (1997) 3.62

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis (1999) 3.62

Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55

Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis (1999) 3.47

Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46

Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44

Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36

Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis (1999) 3.34

A method for the isolation and identification of dengue viruses, using mosquito cell cultures. Am J Trop Med Hyg (1979) 3.13

Genetic diversity among Lassa virus strains. J Virol (2000) 3.00

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99

Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97

A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis (1995) 2.95

West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis (2001) 2.85

Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg (1993) 2.84

Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol (1998) 2.81

Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology (1997) 2.78

Distribution, diversity, and host specificity of Bartonella in rodents from the Southeastern United States. Am J Trop Med Hyg (1997) 2.77

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76

Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol (2004) 2.72

Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet (1996) 2.72

Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol (1985) 2.71

Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl (1996) 2.69

Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg (1997) 2.66

Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64

Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl (1996) 2.63

Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 2.61

Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res (1993) 2.57

Replacement of the natural Wolbachia symbiont of Drosophila simulans with a mosquito counterpart. Nature (1994) 2.56

Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48

The ascension of wildlife rabies: a cause for public health concern or intervention? Emerg Infect Dis (1996) 2.45

Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest (2000) 2.45

Susceptibility of white-tailed deer (Odocoileus virginianus) to infection with Ehrlichia chaffeensis, the etiologic agent of human ehrlichiosis. J Clin Microbiol (1994) 2.44

First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. Am J Trop Med Hyg (2000) 2.44

Differentiation of filoviruses by electron microscopy. Virus Res (1995) 2.39

Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis (1980) 2.38

The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest (2001) 2.38

Association of intraspecific wounding with hantaviral infection in wild rats (Rattus norvegicus). Epidemiol Infect (1988) 2.37

Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev (1993) 2.37

Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis (1999) 2.36

Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36

Ecologic studies of rodent reservoirs: their relevance for human health. Emerg Infect Dis (1999) 2.32

An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 2.32

A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28

Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis (1999) 2.27

Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med (1995) 2.27

Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26

In vitro cultivation of Wolbachia pipientis in an Aedes albopictus cell line. Insect Mol Biol (1997) 2.25

Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med (1996) 2.23

The human ehrlichioses in the United States. Emerg Infect Dis (1999) 2.22

Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis (1999) 2.22

An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. Emerg Infect Dis (1997) 2.19

Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog (2009) 2.17

Use of Bartonella antigens for serologic diagnosis of cat-scratch disease at a national referral center. Arch Intern Med (1995) 2.15

Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology (1991) 2.13

Pathogenesis of a North American hantavirus, Black Creek Canal virus, in experimentally infected Sigmodon hispidus. Am J Trop Med Hyg (1998) 2.11

The phylogeny of New World (Tacaribe complex) arenaviruses. Virology (1996) 2.11

Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Dis (2001) 2.07

Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect (2006) 2.06

Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis (1999) 2.05

Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis (1999) 2.04

Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology (2000) 2.03

Rats of the genus Rattus are reservoir hosts for pathogenic Bartonella species: an Old World origin for a New World disease? J Infect Dis (1999) 2.03

Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology (1994) 2.01

Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. J Infect Dis (1996) 1.99

Proposed antigenic classification of registered arboviruses I. Togaviridae, Alphavirus. Intervirology (1980) 1.98